For this analysis, we focused on expression changes related to inflammatory markers that indicate progression of NAFLD towards a NASH pathology, specifically IL-1α, IL-1β, Ifnγ, and TNFα. The gene discussed is IFNG; the disease is metabolic dysfunction-associated steatohepatitis.